Latest ROE for Lux Health Tech Acquisition - Units (1 Ord Share Class A & 1/3 War): -213.75% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-213.75%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Lux Health Tech Acquisition - Units (1 Ord Share Class A & 1/3 War) (LUXAU) currently reports a ROE of -213.75%. That is below the sector sector average of -5.68%. Use the charts on this page to explore Lux Health Tech Acquisition - Units (1 Ord Share Class A & 1/3 War)'s ROE history and peer comparisons.
Lux Health Tech Acquisition - Units (1 Ord Share Class A & 1/3 War)'s ROE of -213.75% is lower than the its sector sector average of -5.68%. That is roughly 3661.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Lux Health Tech Acquisition - Units (1 Ord Share Class A & 1/3 War)'s current -213.75% should be judged against industry norms (sector average: -5.68%) and against LUXAU's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -213.75%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -5.68%. From there, open related valuation or income-statement pages for Lux Health Tech Acquisition - Units (1 Ord Share Class A & 1/3 War), and consider following LUXAU for alerts when major investors trade the stock.